Analysis of Biphenyl-Type Inhibitors Targeting the Eg5 α4/α6 Allosteric Pocket

Area of Science:

• Biochemistry and Molecular Biology
• Computational Chemistry
• Pharmacology

Background:

• Eg5 (KIF11) is a crucial mitotic kinesin for spindle formation.
• Eg5 is a promising anticancer target due to its role in cell division.
• Biphenyl-type inhibitors offer a unique activity profile compared to other Eg5 inhibitors.

Purpose of the Study:

• To computationally investigate biphenyl-type inhibitors targeting the Eg5 motor protein.
• To understand the role of the flexible L11 loop in biphenyl-type inhibitor binding to Eg5.
• To develop new Eg5 inhibitors through pharmacophore and QSAR modeling.

Main Methods:

• Molecular dynamics (MD) simulations to observe L11 loop conformations.
• Pharmacophore modeling and 3D-QSAR studies.
• Molecular docking and fragment docking analyses.

Main Results:

• MD simulations showed L11 loop stabilization upon Eg5-inhibitor binding via Asn287 hydrogen bonding.
• A pharmacophore model (DDRRH.6) achieved good 3D-QSAR correlation (R²=0.81, Q²=0.64).
• Structure-based pharmacophore identified additional features for improved inhibitor design.

Conclusions:

• Biphenyl-type inhibitors stabilize the Eg5 L11 loop through specific interactions.
• Computational models provide a basis for designing novel and effective Eg5-targeting anticancer agents.
• The study highlights the potential of biphenyl-type compounds for cancer therapy.